Natalia Muzychishin

Natalia Muzychishin currently serves as GRA-CMC Senior Director at Esperion since September 2019. Previously, Muzychishin held the position of Associate Director Regulatory Affairs at Merck from August 2017 to September 2019 and was a Regulatory CMC Consultant at Ophthotech and Kyowa Hakko Kirin Co., Ltd. between 2016 and 2016. Muzychishin's prior experience includes a role as Biopharm Regulatory CMC Manager at GSK from May 2013 to May 2015, focusing on regulatory compliance for biologic products across multiple regions, as well as serving as Regulatory Manager, CMC at Bristol-Myers Squibb from June 2004 to May 2013, providing regulatory support for marketed products. Earlier experience includes a stint as Stability Scientist at both Bristol-Myers Squibb and Merck. Muzychishin holds a Master’s degree in Quality Assurance and Regulatory Affairs and a Bachelor’s degree in Biochemistry, both from Temple University.